Disphar International B.V. is specialised in development and registration of high quality pharmaceutical medicines/registration dossiers with focus on Geographical Europe and foothold in Middle East, Asia, Africa, South America. We have a strong internal co-ordination by project-management teams with highly skilled people and are a partner to all major generic players and innovative pharma industry for development and/or regulatory affairs/supply. We offer to generic and innovative industry: * Broad portfolio of EU (e)CTD dossiers from own development and collaborations; * Marketing authorisations for generics & Value-Added Pharmaceuticals; * Product development (R&D) Services in the broadest sense at Indeus Lab; * Clinical services (trials, bioequivalence studies, etc) at Prague Clinical Studies, also belonging to Nordic Pharma Group; * Supply of finished dosage forms (finished packs or bulk); * QA/QC services. * Partnership & Co-development Disphar International B.V. is a member of the Nordic Pharma Group since 2001. In Sep 2009 Indeus Life Sciences was established, which is operating as our development and laboratory site and can offer development oppertunities, stability studies, etc for external partners. If you are interested in the services or products of Disphar International or Indeus Life Sciences, please feel free to call or email us (see contact details under the "Products & Services tab" and on our website, www.disphar.com).